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The question to be addressed by the work supported by this
contract (NASA Contract No. NGR 09-134-001) was to determine precisely the
effect of stress upon the chemistry of the connective tissue of the rat.
The results of this study took longer to publish than the duration of the
contract itself, but these results are summarized in two papers which
acknowledge NASA support, one in Advances of Biology of Skin, Vol. 10, The
Dermis, edited by Montagna, Bentley, and Dobson, published by Appleton-
Century-Crofts, New York, Chapter 4, page 49, "The Catabolism of Cutaneous
Collagen," (1970); the other in Advances in Enzyme Regulation, Vol. 8,
edited by George Weber, published by Pergamon Press, New York, page 269,
"Control of Cutaneous Collagenolysis," (1970).
Metabolically, insoluble cutaneous collagen has a biological
half-life in the rat of about one year. Despite this low rate of turnover,
within a day after the administration of cortisol (stress hormone), a signi-
ficant amount of this insoluble collagen disappeared from the skin. Since
this loss approximates 500 mg for the skin of a 200 gram rat, or about 25%
of the total cutaneous collagen of this animal, and since the total turnover
for all tissue collagen including bone and tendon has been estimated to be
only 50 mg per rat per day, obviously the inhibition of collagen anabolism
by steroid could not explain the ten-fold greater loss of collagen from the
skin of animals receiving steroid.
Since collagen is entirely extracellular and since steroids
do not lead to the infiltration of blood cells into the connective tissue,
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the rapid loss of skin collagen resulting from steroid administration in vivo
must be mediated by the release of a collagenolytic enzyme into the extra-
cellular space of the tissue.
We have isolated and purified a collagenolytic enzyme which
preexists as an inhibitor-collagenase complex in the extracellular, extrafibular
space of the connective tissue of the skin. This collagenase can be activated
by limited proteolysis of the inhibitor, releasing free collagenase from the
complex. This process takes place during necrosis as the consequence of the
discharge of lysosomal proteases from infiltrating white blood cells-into the
wound space.
This same collagenase has been demonstrated to be induced via
the derepression of an operon in diploid human fibroblasts in vitro by any
steroid containing a -11 OH group. As a consequence of the administration
of cortisol to cultures of diploid human fibroblasts in the absence of usual
serum supplementation of the medium (serum contains an inhibitor of collagenase
activity), there is released into the medium a significant amount of collageno-
lytic enzyme similar in properties to that described previously by us for the
preexisting collagenase of the dermis. This enzyme activity is not released
from fibroblasts in culture when the cells are pretreated with actinomycin D
or with cyclohexamide. This indicates that the synthesis of peptide bonds
and of m-RNA is required for enzymatic activity to appear. The collagenase
has been isolated and purified from the supernatant medium via ammonium
sulfate fractionation, 'Sephadex column chromatography, and isoelectric focusing.
The enzyme has an isoelectric point of pH 5.2 and a maximal activity on collagen
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at pH 5.5. IThe collagenolytic activity is inhibited by phosphate buffer,
serum, and the proteins found in the saline extract of skin. The purified
enzyme has no hydrolytic effect upon denatured hemoglobin or casein. It is
also inhibited by Dilantin but nriot by salicylate.
The reaction products released by this collagenase from
native soluble collagen are a spectrum of variously sized small molecular
weight peptides. These product peptides inhibit the collagenolytic activity
itself as they accumulate in concentration. These product peptides resulting
from the activity of the acid collagenase by both soluble and insoluble
native collagen are further degraded by peptidases which are either also
induced. in the fibroblast or preexist in the skin itself. The amino acids
released from the product peptides of this type of collagenolysis, including
hydroxyproline, are quickly taken up by the liver and, to judge from the iso-
tope data, are converted into liver glycogen.
It is interesting to note that the most effective amino acids
for generating glycogen synthesis in rat liver in vivo are hydroxyproline,
proline, glycine, and alanine; these four amino acids constitute approximately
three-quarters of the amino acids found in collagen. The least effective
amino acids for generating liver glycogen synthesis in vivo are the aromatic
amino acids and the sulfhydral-containing amino acids; essentially none of
which are contained in the structure of collagen.
lTherefore it would appear that via stress hormone-induced
fibroblast collagenase synthesis, the abrupt catabolism of cutaneous collagen
releases small product peptides which can in turn be rapidly degraded to free
amino acids. These collagen-derived amino acids are uniquely active in
effecting liver glycogen synthesis and thereby would provide a major energy
source which could assist the animal in the "fight or flight" reaction to
stress.
Similar collagenase induction and collagen catabolism can
be demonstrated in vivo with traumatic injury, exposure to cold, and
starvation. Thus, we propose that cutaneous collagen represents a hitherto
unrecognized energy reserve pool which can be mobilized via stress hormone
induction of collagenase activity in skin fibroblasts which is released
rapidly into the extracellular space where the collagenase substrate is
located.
The only pharmacologic agent that we could determine that
could inhibit this cutaneous collagenolysis by stress hormone was Dilantin,
as summarized in Chapter 25, page 267 of Antiepileptic Drugs, edited by
Woodbury, Penry, and Sdmidt, published by Raven Press, New York (1972).
The biomechanical consequences of the loss of up to 25% of
insoluble collagen content of the skin remains to be determined. The relevance
of this stress-hormone-induced catabolism of cutaneous collagen to the effects
of null gravity on human connective tissue remains to be determined.
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